Filing Details

Accession Number:
0000711377-13-000028
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-20 17:16:16
Reporting Period:
2013-08-15
Filing Date:
2013-08-20
Accepted Time:
2013-08-20 17:16:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-15 4,499 $18.19 126,186 No 4 M Direct
Common Stock Disposition 2013-08-20 4,499 $53.80 121,687 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2013-08-15 4,499 $0.00 4,499 $18.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
110,319 2013-08-15 No 4 M Direct
Footnotes
  1. Options were granted on 8/15/2008, vested 20% each year on the anniversary date of the grant, and expire on 8/15/2013